You are not logged in.
Please login to continue selecting trials.
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment246% FemaleN/A% WhiteN/A
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRIS-USA-72Data PartnerJohnson & JohnsonCondition StudiedSchizophreniaMean/Median Age (Years)N/A
- Data Definition Specification Available
- Protocol with Amendments Available
- Analysis Datasets Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis
- Harnessing clinical trial data to inform real-world clinical decision making in the treatment of schizophrenia
- Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
- Factors moderating estimates of antipsychotic efficacy in schizophrenia